Building on in vitro characterization of a novel series of soluable gamma-secretase modulators (SGSMs) funded by Cure Alzheimer’s Fund, the current project is a thorough pharmacological or in vivo examination of these molecules to identify the best or “lead” drug candidate.
Novel Soluable Gamma-Secretase Modulators
Funding to date:
© 2005-2017 Cure Alzheimer's Fund. All rights reserved.